For in vitro diagnostic use. Others Elecsys HCG plus beta IVD Elecsys® HCG+β CPS_000481 03 271 749 190 3 271 749 190 03271749190 3271749190 03271749190 HCG+beta Elecsys cobas e 100 V2 Elecsys HCG+beta 04015630919413 Reagents, kits 100 tests cobas e 411/601/602 true 07 251 025 190 7 251 025 190 07251025190 7251025190 07251025190 HCG+beta Elecsys E2G 300 Elecsys HCG+beta 04015630939732 Reagents, kits 300 tests cobas e 402/801 true 09 744 428 190 9 744 428 190 09744428190 9744428190 09744428190 HCG+beta Elecsys E2G 100 V1 Elecsys HCG+ß 07613336217535 Reagents, kits 100 tests cobas e 402/801 true 03271749500 Elecsys HCG+β en 20 FF000000047C760E FF0000000017DF0E 03271749190 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotropin (hCG) plus the hCG β‑subunit in human serum and plasma.This assay is intended for use as an aid in: Early detection and monitoring of pregnancy. The test is also intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations. Oncology, to serve the management of patients with trophoblastic diseases. This assay is useful in the detection and monitoring of hCG‑producing tumor cells of either ovarian, placental or testicular origin. The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07251025500 Elecsys HCG+β en 7 FF00000005D9FA0E FF000000044F160E 07251025190 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotropin (hCG) plus the hCG β‑subunit in human serum and plasma.This assay is intended for use as an aid in:Early detection and monitoring of pregnancy. The test is also intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.Oncology, to serve the management of patients with trophoblastic diseases. This assay is useful in the detection and monitoring of hCG‑producing tumor cells of either ovarian, placental or testicular origin.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en

User profile

Select your user profile

Elecsys^® HCG+β

Overview

Ordering information

Technical documents

Compatible products

Related products

Contact us